Introduction
============

Staphylococci are Gram-positive cocci usually found as transient normal flora of the skin and mucous membranes of mammals and birds and can easily spread to humans by contact and through formites ([@b7-bjm-45-215]). According to [@b2-bjm-45-215] the *Staphylococcus* genus groups together 45 species and 21 subspecies which are classified in two groups based on their ability to produce the enzyme coagulase: coagulase-positive staphylococci (CoPS) and coagulase-negative staphylococci (CoNS).

Thirty-eight different species are found within the CoNS group, including the *S. sciuri* subgroup, which consists of 3 species and 3 subspecies (*S. sciuri* subspecies *rodentium, S. sciuri* subspecies *sciuri, S. sciuri subspecies carnaticus;* S. lentus, and *S. vitulinus*) ([@b15-bjm-45-215]). Staphylococcus sciuri, first described in 1976 by [@b14-bjm-45-215], is the most abundant member of the genus *Staphylococcus* with a wide habitat range ([@b15-bjm-45-215]; [@b16-bjm-45-215]). Although CoNS are saprophytic and rarely pathogenic ([@b16-bjm-45-215]), multi-drug resistant strains have been associated with severe cases of difficult to treat infections, especially in immune compromised individuals ([@b31-bjm-45-215]).

Companion animals, particularly dogs and cats, are frequently implicated as potential reservoirs of methicillin-resistant staphylococci ([@b25-bjm-45-215]). Prevalence of staphylococcal species in companion animals is important because of the potential for zoonotic infections and possibility of resistance genes transfer ([@b23-bjm-45-215]). Human colonization and infections with methicillin-resistant staphylococci (MRS) have been reported in several parts of Nigeria ([@b7-bjm-45-215]; [@b19-bjm-45-215]; [@b8-bjm-45-215]). However, no information exists on the occurrence and molecular characteristics of MRS from dogs in Nigeria. Thus, the objective of this study was to determine the occurrence, resistance phenotypes and molecular mechanisms of resistance of MRS in healthy dogs in Nsukka, Nigeria.

Material and Methods
====================

Sample collection and processing
--------------------------------

Dogs from the university town of Nsukka and four other surrounding communities (Ibagwa Aka, Obollo Afor, Orba, and Opi) were used for the study. A total of 109 clinically healthy dogs consisted of 20 individual household-dogs from the university town, 50 dogs displayed for sale in the local markets in the four communities, and 39 dogs presented to the University of Nigeria Veterinary Teaching Hospital, Nsukka for routine vaccination were sampled. Informed consent of the dog owners was obtained prior to sample collection. The cotton tip of each swab stick was moistened in sterile normal saline and gently rolled over the groin area for about 10 seconds. Each swab sample was streaked on mannitol salt agar (MSA; Oxoid, Basingstoke) supplemented with 10 μg/mL of cloxacillin. Inoculated plates were incubated at 37 °C for 24 to 48 h. On each plate that produced growth, three colonies were randomly selected and purified on nutrient agar. Purified colonies were subjected to Gram staining and catalase test and presumptive staphylococcal colonies (Gram-positive cocci in bunches with positive catalase test) were further evaluated for coagulase production (tube coagulase using rabbit plasma) and haemolysis on 5% sheep blood agar using standard procedures. Representative colony/colonies (if different morphology was shown) from each sample was/were selected for further analysis, including molecular identification.

Identification of staphylococci and methicillin-resistant staphylococci
-----------------------------------------------------------------------

Coagulase-negative staphylococci were identified by PCR amplification followed by sequencing of *sodA* gene ([@b22-bjm-45-215]). The presence of *mec*A in all recovered isolates was investigated by PCR ([@b9-bjm-45-215]).

Antimicrobial resistance pheno- and genotype
--------------------------------------------

Antimicrobial susceptibility of the methicilin-resistant staphylococcal isolates to 17 antimicrobial agents was determined by the agar disk-diffusion method. Antimicrobial agents tested were as follows: penicillin (10 U), oxacillin (1 μg), cefoxitin (30 μg) erythromycin (15 μg), clindamycin (2 μg), gentamicin (10 μg), kanamycin (30 μg), streptomycin (10 U), tobramycin (10 μg), tetracycline (30 μg), trimethoprim-sulphamethoxazole (25 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), mupirocin (200 μg), fusidic acid (10 μg), vancomycin (30 μg), and linezolid (30 μg). The disk-diffusion method and breakpoints recommended by [@b3-bjm-45-215] were employed for all antimicrobials except for streptomycin and fusidic acid, where the methods and breakpoints recommended by the Société Française de Microbiologie (<http://www.sfm.asso.fr>) were used. The double-disk diffusion test (D-test) was performed on all isolates to detect inducible clindamycin resistance.

The presence of the following 30 antimicrobial resistance genes was investigated by PCR: *mec*A, *blaZ*, *tet*(K), *tet*(M), *tet*(L), *erm*(A), *erm*(B), *erm*(C), *erm*(T), *mph*(C), *msr*(A), *msr*(B), *lnu*(A), *vga*(A), *vga*(C), *aacA-aphD*, *aphA-3*, *aadD*, *aadE*, *aadA*, *str*, *dfr*(A), *dfr*(D), *dfr*(G), *dfr*(K), *fexA*, *cfr*, *cat~pC194~*, *cat~pC221~*, and *cat~pC223~* ([@b27-bjm-45-215]; [@b10-bjm-45-215]). Positive controls from the collection of the University of La Rioja were included in each PCR reaction.

Results
=======

Occurrence of methicillin-resistant staphylococcal species
----------------------------------------------------------

Sixteen methicillin-resistant coagulase negative staphylococci (MRCoNS), all harbouring the *mecA* gene were isolated from 14 (12.8%) of the 109 dogs sampled. The MRCoNS isolated belonged to four different species namely: *S. sciuri* subspecies *rodentium*, *S. lentus*, *S. haemolyticus*, *and S. simulans*, with *S. sciuri* subspecies *rodentium* (62.5%) being the predominant species detected ([Figure 1](#f01){ref-type="fig"}).
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Resistance pheno- and genotype of the MRS to other antimicrobials
-----------------------------------------------------------------

Resistance phenotype of the staphylococcal isolates investigated as well as their corresponding molecular mechanisms of resistance are shown in [Table 1](#t01){ref-type="table"}. Thirteen (81.3%) of the MRCoNS were resistant to tetracycline while 12 (75%) and 10 (62.5%) were resistant to kanamycin and trimethoprim-sulphamethoxazole respectively. None of the isolates was resistant to fusidic acid, linezolid and vancomycin. High rate of multi-drug resistance (MDR) was observed among the MRCoNS as 13 (81.3%) of them were resistant to more than 3 classes of antimicrobial agents.

###### 

Species, antimicrobial resistance phenotype and resistance genes detected among MRCoNS isolated from dogs in Nuskka, Nigeria.

  Strain ID   Staphylococcal species           Resistance phenotype[a](#tfn01){ref-type="table-fn"}   Resistance genes detected
  ----------- -------------------------------- ------------------------------------------------------ ---------------------------------------------------------------------------------
  C2854       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-GEN-KAN-TOB-SXT-CHL            mecA, *tet*(K), *tet*(M), *erm*(B), *aacA-aphD, cat~pC223~*
  C2869       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-GEN-KAN-SXT-CHL-CIP            mecA, *tet*(K), *erm*(B), *lnu*(A), *aacA-aphD, cat~pC221~*
  C2853       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-GEN-KAN-STR-SXT                mecA, *tet*(K), *erm*(B), *aacA-aphD*
  C2865       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-GEN-KAN-STR-SXT                mecA, *tet*(K), *tet*(M), *erm*(B), *lnu*(A), *aacA-aphD*
  C2855       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-KAN-SXT-CHL                    mecA, *tet*(K), *tet*(M), *erm*(B), *lnu*(A), *aacA-aphD, cat~pC221~*
  C2867       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-KAN-SXT-MUP                    mecA, *tet*(K), *tet*(M), *erm*(B), *lnu*(A), *aacA-aphD*
  C2864       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-GEN-KAN                        mecA, *tet*(K), *tet*(M), *erm*(B), *aacA-aphD*
  C2866       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-TET-ERY-CLI-KAN                            mecA, *tet*(K), *tet*(M), *erm*(B), *lnu*(A), *aacA-aphD*
  C2852       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX-CHL                                        mecA, *cat~pC223~*
  C2871       *S. sciuri* subsp. *Rodentium*   PEN-OXA-FOX                                            mecA
  C2861       *S. lentus*                      PEN-OXA-FOX-TET-ERY-CLI-KAN-SXT-CHL                    mecA, *tet*(K), *tet*(M), *tet*(L), *erm*(B), *aacA-aphD, dfr*(G), *cat~pC221~*
  C2860       *S. lentus*                      PEN-OXA-FOX-TET-STR-SXT                                mecA, *str, dfr*(G)
  C2871-2     *S. lentus*                      PEN-OXA-FOX-TET-KAN                                    mecA, *tet*(K), *tet*(M), *aacA-aphD*
  C2873       *S. haemolyticus*                PEN-OXA-FOX-TET-KAN-SXT-CHL                            mecA, *tet*(K), *aacA-aphD, aphA3, dfr*(G), *cat~pC221~*
  C2870       *S. haemolyticus*                PEN-OXA-FOX-TET-KAN-SXT-CHL                            blaZ, mecA, *tet*(K), *aacA-aphD, dfr*(G), *cat~pC221~*
  C2857       *S. simulans*                    PEN-OXA-FOX                                            mecA

PEN, penicillin; OXA, oxacillin; FOX, cefoxitin; TET, tetracycline; ERY, erythromycin; CLI, clindamycin; GEN, gentamicin; KAN, kanamycin; TOB, tobramycin; STR, streptomycin; SXT, trimethoprim-sulphamethoxazole; CHL, chloramphenicol; MUP, mupirocin; CIP, ciprofloxacin.

MRCoNS, Methicillin-resistant coagulase negative staphylococci.

The percentage of each antimicrobial resistance gene and/or gene combination detected among the MRCoNS isolates is presented in [Figure 2](#f02){ref-type="fig"}. The nine (56.3%) erythromycin resistant isolates were also resistant to clindamycin. Constitutive clindamycin resistance was observed in all but 3 MRCoNS isolates. These 3 isolates revealed the typical D-shaped halo around clindamycin disk, characteristic of inducible clindamycin resistance. [Table 1](#t01){ref-type="table"} and [Figure 2](#f02){ref-type="fig"} show the different resistance genes detected among isolates. In some cases, the resistance mechanism implicated could not be detected even though a wide variety of resistance genes were tested. Six of the 10 MRCoNS that were also resistant to trimethoprim-sulphamethoxazole lacked any of the so far described genes encoding trimethoprim resistance \[*dfr*(A), *dfr*(D), *dfr*(G), *dfr*(K)\]. Based on these results, trimethoprim (5 μg/mL) and sulfonamide (20 μg/mL) antimicrobial agents were tested separately ([@b3-bjm-45-215]) and the results revealed that all trimethoprim-sulphamethoxazole resistant strains were also trimethoprim resistant. One methicillin-resistant *S. sciuri* subspecies *rodentium* (C2867) was resistant to mupirocin but *mupA* gene was not detected.
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Discussion
==========

Resistance of staphylococci to methicillin and other antimicrobials is a global problem in the chemotherapy of staphylococcal infections. As pointed out by [@b12-bjm-45-215], this resistance has underscored the need for species identification which is an important step for monitoring the reservoir and distribution of these bacteria. In the present study, the major MR staphylococcal group present in the groin area of dogs in Nsukka was CoNS, with *S. sciuri* subspecies *rodentium,* being the predominant species and subspecies identified. Although CoNS are saprophytic and rarely pathogenic ([@b15-bjm-45-215]), they have been associated with opportunistic infections, especially in immunocompromised individuals ([@b31-bjm-45-215]). Previous studies have shown *S. sciuri* to be present not only as part of the skin, nasal and oral microflora of healthy dogs, but also as a causative agent of infections, although at lower rates than *S. pseudintermedius* ([@b28-bjm-45-215]; [@b11-bjm-45-215]). *Staphylococcus sciuri* was among the staphylococcal strains isolated from cases of canine pyoderma in Natal City, Brazil ([@b17-bjm-45-215]). A case of human wound infection by a multidrug resistant strain of *S. sciuri* has been reported ([@b4-bjm-45-215]). Thus, this staphylococcal species could constitute a health risk to both humans and animals especially when the natural mucocutaneous barrier is breached. *Staphylococcus sciuri* has been described as a natural reservoir of the methicillin resistance gene, *mec*A ([@b16-bjm-45-215]; [@b5-bjm-45-215]), which may explain the high rate of *mec*A positive *S. sciuri* recorded in the present study. The other MRCoNS isolated in this study, although at low rates, have also been reported in dogs as commensal and/or pathogens ([@b11-bjm-45-215]).

The absence of MRCoPS colonization among the tested dog population is similar to the findings of [@b30-bjm-45-215] and [@b1-bjm-45-215] who failed to detect the organism in healthy dogs in Slovenian and a community in United Kingdom, respectively. However, low MRCoPS carriage rates in healthy dogs have been reported by other authors ([@b10-bjm-45-215]; [@b18-bjm-45-215]), with *S. pseudintermedius* as the prominent MRCoPS species, even though their occurrence is still low (0--4.5%) ([@b9-bjm-45-215]; [@b29-bjm-45-215]). Failure to detect methicillin-resistant *S. aureus* and *S. pseudintermedius* among the sampled dogs suggests that these species are not predominant methicillin-resistant staphylococci in the study area. Alternatively, groin swabs from healthy dogs were used in the present study whereas most reports on *S. pseudintermedius* in dogs used nasal, skin, perineal or combined body-site samples ([@b24-bjm-45-215]; [@b29-bjm-45-215]). It could therefore appear that the groin area of dogs is less colonized by methicillin-resistant *S. pseudintermedius* than the mucous or skin.

High rate of MDR was observed among the MRCoNS as 81.3% of them were resistant to more than 3 classes of antimicrobial agents. Cross resistance to other antimicrobials is most common in methicillin-resistant than in methicillin-sensitive staphylococcal isolates ([@b21-bjm-45-215]; [@b13-bjm-45-215]). In our MRCoNS isolates, cross-resistance was due in most cases to tetracyclines, aminoglucosides, trimethoprim-sulphamethoxazole and/or macrolides-lincosamides. Interestingly, our isolates were recovered from healthy animals whereas nosocomial strains are more likely to be MDR than commensal ([@b13-bjm-45-215]).

Only 2 of the 16 MRCoNS (both being *S. sciuri* subspecies *rodentium*) had the same resistance phenotype; indicating a high diversity of antimicrobial resistance profiles among the strains. Interestingly, no tetracycline resistance gene was detected in 1 tetracycline-resistant MR *S. sciuri* subspecies *rodentium* (C2860) ([Table 1](#t01){ref-type="table"}, [Figure 2](#f02){ref-type="fig"}). Furthermore, 2 streptomycin-resistant MR S. sciuri subspecies rodentium did not present any streptomycin resistance genes, while 5 trimethoprim-sulphamethxazole resistant strains (again MR S. sciuri subsps. rodentium) equally did not harbour any of the so far described trimethoprim-sulphamethxazole resistant genes for staphylococci ([Table 1](#t01){ref-type="table"}, [Figure 2](#f02){ref-type="fig"}). Chromosomal mutations conferring high-level resistance to streptomycin and over-expression of the enzyme dihydrofolate reductase (DHFR), target of trimethoprim, have been described ([@b27-bjm-45-215]). It is also interesting to remark that one MR *S. sciuri subsps. rodentium* (C2867) was resistant to mupirocin but *mupA* gene could not be detected. Previous studies have shown an association between mupirocin usage and emergence of mupirocin resistance in staphylococci ([@b20-bjm-45-215]). However, mupirocin is not known to be used in veterinary practice in Nigeria, thus, mupirocin resistance in one of the *Staphylococcus* strain in the present study may not be attributed to mupirocin usage. These data altogether suggest the potential presence of novel characteristics and presents *S. sciuri* as a potential reservoir of novel antimicrobial resistant properties.

The findings in this study highlight the existence of MDR strains of MRCoNS, particularly *S. sciuri* subspecies *rodentium,* in healthy dogs in Nsukka, Nigeria. Since dogs are in close contact with their owners, the risk of transmission of MDR staphylococci between animals and humans as well as the possibility of transfer of *mec*A and other resistance genes from the CoNS to human pathogenic *S. aureus* are serious public health concerns.
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